Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 11,677-11,688 of 23,847
Drug study icon
CompletedNCT00759473

D-Cycloserine Facilitation of Cocaine - Cue Extinction

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Charleston
Mental healthDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United States
Sponsor
Medical University of South Carolina
Condition
Mental health
Drug study icon
CompletedNCT02156908

D-serine and Cognitive Remediation in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Orangeburg
SchizophreniaDrugFrom 18 Years to 64 Years
Countries
United States
Sponsor
Nathan Kline Institute for Psychiatric Research
Condition
Schizophrenia
Drug study icon
SuspendedNCT05046353

D-serine AudRem: R33 Phase

This study exists to understand what helps a medication treatment work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.

In New York
SchizophreniaDrugFrom 18 Years to 50 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
Drug study icon
CompletedNCT03711500

D-serine Augmentation of Neuroplasticity

This study exists to understand what helps a digital app or remote support tool work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.

Multiple locations, including New York
SchizophreniaDrugFrom 18 Years to 50 Years
Countries
United States
Sponsor
New York State Psychiatric Institute
Condition
Schizophrenia
Drug study icon
CompletedNCT00215878

D-serine for PTSD Treatment

This summary needs review. Please check the official study record and contact the research team for details.

In Jerusalem
PTSDDrugFrom 25 Years to 75 Years
Countries
Israel
Sponsor
Herzog Hospital
Condition
PTSD
Drug study icon
CompletedNCT00826202

D-serine for the Schizophrenia Prodrome

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including New Haven
SchizophreniaDrugFrom 13 Years to 35 Years
Countries
United States
Sponsor
Nathan Kline Institute for Psychiatric Research
Condition
Schizophrenia
Drug study icon
CompletedNCT00816894

D-serine Monotherapy for Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Jerusalem
SchizophreniaDrugFrom 18 Years to 70 Years
Countries
Israel
Sponsor
Herzog Hospital
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.